BlackRock last year staked its claim in the alternative asset business, spending nearly $30bn to buy two marquee private investment shops, as well as one of the main data providers to the entire ...

BlackRock is pulling out of a United Nations-sponsored climate initiative, a remarkable U-turn for a company that was once a poster child of the environmental, social and governance investing movement ...

With such a wide range of potential outcomes this year, risk management and value capture will be important themes.

One of Bitcoin’s major drawbacks is its 10-minute transaction time, which has allowed faster networks like Ethereum, Solana, ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

In a tough year for stockpickers, a handful of funds managed to trounce the market. Here’s how they did it—and what they like ...

Goldman Sachs Chief APAC Regional Equity Strategist Timothy Moe was largely upbeat on Chinese stocks during an interview with ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Halozyme Therapeutics stock is trading -17.97% below its average target price of $64.12 after marking a 2.8% during today's morning session. Analysts are giving the Mid-Cap Biotechnology company an ...

Mauricio Di Bartolomeo, reflects on the choices he and his co-founder have made that have led to their six years of success.

It is another year of opportunities, and 2025 will be the year for Bitcoin. After the 100k milestone, more fantastic ...

How long can the boom in private credit last? Practically everyone on Wall Street concedes that this moment is bound to dim ...